Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

CAPS Rating: 4 out of 5

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.


Player Avatar anchor68 (55.06) Submitted: 9/15/2011 8:09:04 PM : Outperform Start Price: $17.70 MNTA Score: -104.64

One word says it all: Generics- People not only want Affordable medications, they Demand it!!!

Featured Broker Partners